Optimi Health Corp. (OPTH) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Optimi Health Corp. stock $1.45, price $2.15, that is 32.6% below the price, quality 26 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Optimi Health Corp.
OPTH · USExpensive (fair value 33% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range $2.11 – $23.74 · fair‑value band $1.09 – $1.82 · the $2.15 price screens above the $1.45 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Optimi Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.
Show moreShow less
The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.
The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online.
Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Stock analysis
Optimi Health Corp. (OPTH) currently trades at $2.15, while our estimate is $1.45, 33% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $1.09 (bear) to $1.82 (bull), the price of $2.15 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 26/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Optimi Health Corp. reported revenue of C$427K in FY2025 versus C$80.7K in FY2022, a compound +74.2%/yr. Reported net income was −C$3.7M in FY2025.
Key figures
Market cap $12.3M Micro · P/S ratio 70.1 · EPS (TTM) $−1.56 · Return on equity −54.4% · Return on assets (EBIT) −31.4% (5-year average) · Operating margin −2,926% · Revenue (TTM) C$176K · Revenue growth (YoY) −28.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (medium confidence).
What moves the price
The share trades about 75% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −33%, OPTH screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
OPTH screens overvalued: fair value 33% below the price. Compare with Merck KGaA →
Compare Optimi Health Corp. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- Stock screener with 62 metrics
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $84.39 | $113.53 | +35% | vs OPTH |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.02 | ¥53.04 | +10% | vs OPTH |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,868 | ₹1,983 | +6% | vs OPTH |
| Haleon plc HLN | $9.20 | $8.47 | −8% | vs OPTH |
| Merck KGaA MRK | €149.70 | €108.83 | −27% | vs OPTH |
| Galderma Group GALD | CHF 191.00 | CHF 112.46 | −41% | vs OPTH |
| Takeda Pharmaceutical Company TAK | $21.59 | $11.23 | −48% | vs OPTH |
| Teva Pharmaceutical Industries Limited TEVA | $42.57 | $20.74 | −51% | vs OPTH |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs OPTH |
| Divi's Laboratories Limited DIVISLAB | ₹11,080 | ₹1,567 | −86% | vs OPTH |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Optimi Health Corp. (OPTH) overvalued or undervalued?
What is the fair value of OPTH?
What is the quality score of OPTH?
What is the price target for Optimi Health Corp. (OPTH)?
What is the Optimi Health Corp. stock forecast for 2026?
What is the revenue of Optimi Health Corp. (OPTH)?
What is the intrinsic value of Optimi Health Corp. (OPTH)?
Is Optimi Health Corp. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of OPTH?
How much is Optimi Health Corp. worth?
What do the bullish and bearish scenarios say about OPTH?
How solid is the balance sheet of Optimi Health Corp. (OPTH)?
How far is OPTH from its 52-week high?
Which stocks are comparable to Optimi Health Corp.?
Is Optimi Health Corp. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Optimi Health Corp. (OPTH)?
What should I pay attention to with Optimi Health Corp. right now?
Key figures of Optimi Health Corp.
How large is the market capitalisation of Optimi Health Corp. (OPTH)?
What is the P/S ratio of Optimi Health Corp. (OPTH)?
What are the earnings per share of Optimi Health Corp. (OPTH)?
What is the return on equity of Optimi Health Corp. (OPTH)?
What is the EBIT return on assets of Optimi Health Corp. (OPTH)?
What is the operating margin of Optimi Health Corp. (OPTH)?
How fast is revenue growing at Optimi Health Corp. (OPTH)?
How much free cash flow does Optimi Health Corp. (OPTH) generate?
How much net debt does Optimi Health Corp. (OPTH) carry?
Watch Optimi Health Corp. in the live analysis
One click puts Optimi Health Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.